| P50 | author | Henry L Halliday | Q37830444 |
| | Lex Doyle | Q37838595 |
| | Richard A. Ehrenkranz | Q110527546 |
| P2860 | cites work | Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia | Q28324530 |
| | Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants | Q28373949 |
| | Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants | Q30649367 |
| | Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. | Q30867509 |
| | Growth retardation after dexamethasone administration: assessment by knemometry | Q33623976 |
| | Clinical trials of postnatal corticosteroids: inhaled and systemic | Q33678768 |
| | Maternal nutrition and birth weight. These factors are related | Q33800596 |
| | Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function | Q33888778 |
| | Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants | Q35286092 |
| | Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease | Q35287062 |
| | Early postnatal dexamethasone treatment and increased incidence of cerebral palsy | Q35290082 |
| | Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome | Q36500274 |
| | Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome | Q36859749 |
| | The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia | Q38365940 |
| | Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial | Q41204668 |
| | Inflammatory mediators and bronchopulmonary dysplasia | Q42117443 |
| | Early dexamethasone therapy in preterm infants: a follow-up study | Q42542989 |
| | Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed | Q42765211 |
| | Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network | Q43517486 |
| | Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia | Q44657338 |
| | Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study | Q44682791 |
| | Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity | Q44814826 |
| | A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants | Q45030708 |
| | Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial | Q45170114 |
| | Trial of early neonatal hydrocortisone: two-year follow-up | Q45492296 |
| | Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants | Q46471678 |
| | A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants | Q46923291 |
| | Randomized placebo-controlled trial of a 42-Day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants | Q47262295 |
| | Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants | Q47281085 |
| | The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study | Q47761133 |
| | Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy | Q47804932 |
| | Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. | Q47977697 |
| | A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants | Q48114189 |
| | The therapeutic use of glucocorticoid hormones in the perinatal period: Potential neurological hazards | Q48253384 |
| | The influence of betamethasone and dexamethasone on motor development in young rats | Q48429585 |
| | Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. | Q50949616 |
| | Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. | Q52119180 |
| | Early dexamethasone treatment in preterm infants treated with surfactant: a double blind controlled trial. | Q54567376 |
| | Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants | Q57837984 |
| | Using cerebral palsy data in the evaluation of neonatal intensive care: a warning | Q70427122 |
| | Influence of postnatally administered glucocorticoids on rat lung growth | Q70947874 |
| | Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants | Q71554956 |
| | Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia | Q72712741 |
| | Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome | Q72744647 |
| | Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone | Q73071398 |
| | Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial | Q73102345 |
| | Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation | Q73205359 |
| | Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants | Q73241410 |
| | Early dexamethasone-attempting to prevent chronic lung disease | Q73502499 |
| | Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial | Q73732130 |
| | The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome | Q74198285 |
| | Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy | Q74451868 |
| | Effect of dexamethasone therapy on the neonatal ductus arteriosus | Q74501146 |
| | Single-dose dexamethasone treatment of hypotension in preterm infants | Q77835234 |
| | A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial | Q77949904 |
| | Early dexamethasone therapy and blood cell count in preterm infants | Q78198724 |
| | Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants | Q78200707 |
| | Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial | Q80475751 |
| | More trials on early treatment with corticosteroids are needed | Q95804825 |
| P921 | main subject | lung disease | Q3392853 |
| | preterm infant | Q45051448 |
| P577 | publication date | 2010-01-20 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants | |